SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-037195
Filing Date
2019-06-24
Accepted
2019-06-24 16:01:57
Documents
4
Period of Report
2019-06-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-12058_18k.htm 8-K 34327
2 EX-10.1 a19-12058_1ex10d1.htm EX-10.1 81427
3 EX-99.1 a19-12058_1ex99d1.htm EX-99.1 13059
4 GRAPHIC g120581mmi001.jpg GRAPHIC 4723
  Complete submission text file 0001104659-19-037195.txt   136955
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 19915256
SIC: 2835 In Vitro & In Vivo Diagnostic Substances